|
|
| | Barmastine Basic information |
| Product Name: | Barmastine | | Synonyms: | Barmastine;3-[2-[4-[(3-Furfuryl-3H-imidazo[4,5-b]pyridin-2-yl)amino]piperidino]ethyl]-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one;R-57959;Ramastine;3-[2-[4-[[3-(furan-2-ylmethyl)imidazo[4,5-b]pyridin-2-yl]amino]piperidin-1-yl]ethyl]-2-methylpyrido[1,2-a]pyrimidin-4-one | | CAS: | 99156-66-8 | | MF: | C27H29N7O2 | | MW: | 483.573 | | EINECS: | | | Product Categories: | | | Mol File: | 99156-66-8.mol |  |
| | Barmastine Chemical Properties |
| | Barmastine Usage And Synthesis |
| Originator | Barmastine,ZYF Pharm Chemical | | Uses | Antihistaminic. | | Manufacturing Process | A mixture of N-(3-nitro-2-pyridinyl)-2-furanylmethanamine, of a solution of
thiophene in ethanone 4% and of methanol saturated with ammonia was
hydrogenated at normal pressure and at room temperature with platinum-on-charcoal catalyst 5%. After the calculated amount of hydrogen was taken up,
the catalyst was filtered off and the filtrate was evaporated. The residue was
crystallized from acetonitrile, yielding the N2-(2-furanylmethyl)-2,3-
pyridinediamine.
A mixture of 54 parts of ethyl 4-isothiocyanato-1-piperidinecarboxylate, 48
parts of N2-(2-furanylmethyl)-2,3-pyridinediamine and 450 parts of
tetrahydrofuran was stirred and refluxed overnight. The reaction mixture was
evaporated and the residue was crystallized from a mixture of 2-propanone
and 2,2'-oxybispropane. The product was filtered off and dried, yielding 76
parts (75%) of ethyl 4-[[[2-[(2-furanylmethyl)amino]-3-
pyridinyl]aminothioxomethyl]amino]-1-piperidinecarboxylate; melting point
132.7°C.
A mixture of 74 parts of ethyl 4-[[[2-[(2-furanylmethyl)amino]-3-
pyridinyl]aminothioxomethyl]amino]-1-piperidinecarboxylate, 96 parts of
mercury (II) oxide, 0.1 parts of sulfur and 800 parts of ethanol was stirred
and refluxed for 3 h. The reaction mixture was filtered over Hyflo and the
filtrate was evaporated to give 52.5 parts (79%) of ethyl 4-[[3-(2-
furanylmethyl)-3H-imidazo[4,5-b]pyridin-2-yl]amino]-1-piperidinecarboxylate;
melting point 149.2°C (crystallized from acetonitrile).
A mixture of ethyl 4-[[3-(2-furanylmethyl)-3H-imidazo[4,5-b]pyridin-2-
yl]amino]-1-piperidinecarboxylate and of a hydrobromic acid solution 48% in
water was stirred and heated for 3 h at about 80°C. The reaction mixture was
evaporated and the residue was dried, yielding the 3-(2-furanylmethyl)-N-(4-
piperidinyl)-3H-imidazo[4,5-b]pyridin-2-amine dihydrobromide (crystallized
from methanol).
A mixture of 3-(2-hydroxyethyl)-2-methyl-pyrido[2,1-b]pyrimidin-4-one, of
acetic acid and of a hydrobromic acid solution 67% in acetic acid was stirred
and heated to reflux. Stirring was continued overnight at reflux temperature.
The reaction mixture was evaporated and the solid residue was triturated in 2-
propanone. The product was filtered off and dried, yielding 3-(2-bromoethyl)-
2-methyl-pyrido[1,2-a]pyrimidin-4-one monohydrobromide.
A mixture of 3-(2-bromoethyl)-2-methyl-pyrido[1,2-a]pyrimidin-4-one
monohydrobromide, 3-furan-2-yl-methyl-(3H-imidazo[4,5-b]pyridine-2yl)-4-
piperidinyl)-amine dihydrobromide, of sodium carbonate and of N,Ndimethylformamide
was stirred and heated overnight at about 70°C. The
reaction mixture was poured onto water. The product was extracted with
trichloromethane. The extract was dried, filtered and evaporated. The residue
was purified by column chromatography over silica gel using a mixture of
trichloromethane and methanol (94:6 by volume), saturated with ammonia,
as eluent. The pure fractions were collected and the eluent was evaporated.
The residue was crystallized from acetonitrile, yielding 3-(2-(4-((3-(2-
furanylmethyl)-3H-imidazo[4,5-b]pyridin-2-yl)amino)-1-piperidinyl)ethyl)-2-
methyl-4H-pyrido[1,2-a]pyrimidin-4-one; melting point 202°C. | | Therapeutic Function | Antihistaminic |
| | Barmastine Preparation Products And Raw materials |
|